PL394863A1 - Lek przeciwnowotworowy, sposób jego wytwarzania oraz sposób jego stabilizacji - Google Patents

Lek przeciwnowotworowy, sposób jego wytwarzania oraz sposób jego stabilizacji

Info

Publication number
PL394863A1
PL394863A1 PL394863A PL39486309A PL394863A1 PL 394863 A1 PL394863 A1 PL 394863A1 PL 394863 A PL394863 A PL 394863A PL 39486309 A PL39486309 A PL 39486309A PL 394863 A1 PL394863 A1 PL 394863A1
Authority
PL
Poland
Prior art keywords
stabilization
preparation
anticancer drug
anticancer
drug
Prior art date
Application number
PL394863A
Other languages
English (en)
Other versions
PL219734B1 (pl
Inventor
Ilima Iliodorovna Volchenskova
Nadezhda Nikolaevna Maydanevich
Original Assignee
Sokyrko Oleg Sergeevich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from UAA200906849A external-priority patent/UA90233C2/uk
Application filed by Sokyrko Oleg Sergeevich filed Critical Sokyrko Oleg Sergeevich
Publication of PL394863A1 publication Critical patent/PL394863A1/pl
Publication of PL219734B1 publication Critical patent/PL219734B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL394863A 2008-12-22 2009-11-23 Lek przeciwnowotworowy, sposób jego wytwarzania oraz sposób jego stabilizacji PL219734B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UA200814666 2008-12-22
UAA200906849A UA90233C2 (uk) 2009-06-30 2009-06-30 Спосіб стабілізації протипухлинних засобів на основі водного розчину сполуки платини з дезоксирибонуклеїновою кислотою

Publications (2)

Publication Number Publication Date
PL394863A1 true PL394863A1 (pl) 2011-09-26
PL219734B1 PL219734B1 (pl) 2015-07-31

Family

ID=42288021

Family Applications (1)

Application Number Title Priority Date Filing Date
PL394863A PL219734B1 (pl) 2008-12-22 2009-11-23 Lek przeciwnowotworowy, sposób jego wytwarzania oraz sposób jego stabilizacji

Country Status (8)

Country Link
CN (1) CN102227222B (pl)
BG (1) BG66625B1 (pl)
BR (1) BRPI0923273A2 (pl)
EA (1) EA015680B1 (pl)
IL (1) IL213446A (pl)
PL (1) PL219734B1 (pl)
TR (1) TR201104008T1 (pl)
WO (1) WO2010074662A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102784098A (zh) * 2011-05-20 2012-11-21 湖南省湘中制药有限公司 丙戊酸镁注射液及其制备工艺
CN110755447A (zh) * 2013-01-04 2020-02-07 德克萨斯系统大学董事会 包含柠檬酸的组合物及其应用
CN104027301B (zh) * 2013-03-05 2017-05-10 肖云彩 一种奥拉西坦组合物注射液
RU2667128C2 (ru) 2016-12-29 2018-09-14 Герман Петрович Беккер Композиция для приготовления противоопухолевого средства и способ приготовления противоопухолевого средства на ее основе

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534513A (en) * 1991-09-05 1996-07-09 Taiho Pharmaceutical Company, Ltd. Antitumor potentiator and antitumor composition
UA70455A (en) * 2003-09-23 2004-10-15 Serhii Oleksandrovych Shalimov Antineoplastic platinum drug for topical treatmentantineoplastic platinum drug for topical treatment of oropharyngeal cancer and method for its usage of oropharyngeal cancer and method for its usage
UA70456A (en) * 2003-09-23 2004-10-15 Serhii Oleksandrovych Shalimov Dosage form of infusional antineoplastic drug and dosage form of infusional antineoplastic drug and method for its production method for its production

Also Published As

Publication number Publication date
WO2010074662A1 (ru) 2010-07-01
EA201100618A1 (ru) 2011-10-31
PL219734B1 (pl) 2015-07-31
CN102227222A (zh) 2011-10-26
IL213446A (en) 2013-11-28
EA015680B1 (ru) 2011-10-31
BG110926A (bg) 2011-10-31
CN102227222B (zh) 2012-11-21
BRPI0923273A2 (pt) 2014-01-28
BG66625B1 (bg) 2017-12-15
TR201104008T1 (tr) 2011-10-21
IL213446A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
ZA201007526B (en) Process for the preparation of 2,3,3,3-tetrafluoropropene
ZA201007983B (en) Process for the preparation of 2,3,3,3-tetrafluoropropene
ZA201208198B (en) Picolinamide and pyrimidine-4-carboxamine compounds, process for preparing and pharmaceutical composition comprising the same
IL238438A0 (en) 2,2,2-trifluoroacetophenones and a method for their preparation
AP2012006135A0 (en) Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof.
IL205759A (en) History of isoxazolo-pyridine, a process for their preparation and the drugs containing them
ZA201102760B (en) Process for preparing chlorins and their pharmaceutical uses
IL216826A0 (en) Pyridil-triazine derivatives, compositions comprising the same and processes for producing the same
ZA201004497B (en) Process for manufacturing stamped products,and stamped products prepared from the same
IL217208A (en) History of cryptophycin, critophycin conjugates, processes for their preparation, and their use as anticancer agents
IL208832A0 (en) 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
PL2271606T3 (pl) Sposób wytwarzania 1,2,3,3,3-pentafluoropropenu-1
ZA201201349B (en) Dihydropteridinone derivatives, preparation process amd pharmaceutical use thereof
EP2351764A4 (en) TREHALOSE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND
ZA201301726B (en) Crystal 6,7-unsaturated-7-carbamoyl morphinan derivative,and method for producing the same.
ZA201301463B (en) Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same
ZA201006639B (en) Nanoparticle carriers for drug administration and process for producing the same
IL216388A0 (en) New compounds, pharmaceutical composition and methods relating thereto
IL217053A0 (en) Nanoparticulate candesarten cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them
IL233055A0 (en) (1r,r4) 7-oxo-2-azabicyclo [2.2.2] oct-5-ene and its derivatives
PL394863A1 (pl) Lek przeciwnowotworowy, sposób jego wytwarzania oraz sposób jego stabilizacji
PH12012500315A1 (en) Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same
PL393268A1 (pl) Kwas 2-amino-6-dihydroksyborylo-1,2,3,4-tetrahydronaftaleno-2-karboksylowy i sposób jego wytwarzania
AP2012006352A0 (en) AzabicycloÄ3.1.0Ühex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same.
IL210049A0 (en) Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it